GT BIOPHARMA INC (GTBP)

US36254L3087 - Common Stock

3.345  -0.41 (-10.84%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
13.58M21.26M57.52M6.77M11.46M
Research and Development
6.47M8.81M9.59M490.00K1.67M
Selling, General, and Administrative Expenses
7.11M12.45M47.92M6.28M9.79M
Operating Income
-13.58M-21.26M-57.52M-6.77M-11.46M
Interest Income/Expense
615.00K370.00K-500.00K-3.23M-2.13M
Other Income/Expense
4.82MN/A0.00-12.92MN/A
Non Recurring Items
547.00KN/A0.00-5.38M-4.60M
Income Before Taxes
-7.60M-20.88M-58.01M-28.30M-38.65M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-7.60M-20.88M-58.01M-28.30M-38.65M
EBITDA
N/AN/AN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-5.64-0.66-2.06-6.45-11.42
Non GAAP EPS
-5.79-5.89-2.67N/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts